Praxis Precision Medicines, Inc.
Records under this name other than the patents Praxis Precision Medicines, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 40 patents it holds.
Back to Praxis Precision Medicines, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| 16/464,467 | Compounds and Their Methods of Use Abandoned Abandoned Jun 5, 2022 | Abandoned | Abandoned Jun 5, 2022 | |
| 16/472,576 | T-Type Calcium Channel Modulators and Methods of Use Thereof held by Monash University Abandoned Abandoned Nov 18, 2022 | Abandoned | Abandoned Nov 18, 2022 | |
| 16/613,994 | Methods of Treating Epilepsy and Neurodevelopmental Disorders Abandoned Abandoned Sep 8, 2020 | Abandoned | Abandoned Sep 8, 2020 | |
| 16/716,252 | Methods for the Treatment of Depression Abandoned Abandoned Aug 11, 2020 | Abandoned | Abandoned Aug 11, 2020 | |
| 16/912,327 | Methods for the Treatment of Depression Abandoned Abandoned Oct 25, 2022 | Abandoned | Abandoned Oct 25, 2022 | |
| 17/143,602 | Salts and Crystal Forms of Gaba-A Positive Allosteric Modulator Abandoned Abandoned May 6, 2024 | Abandoned | Abandoned May 6, 2024 | |
| 17/413,815 | Methods for the Treatment of Depression Abandoned Abandoned Dec 12, 2024 | Abandoned | Abandoned Dec 12, 2024 | |
| 17/415,164 | Compositions and Methods for the Treatment of KCNT1 Related Disorders Abandoned Abandoned Dec 5, 2024 | Abandoned | Abandoned Dec 5, 2024 | |
| 17/424,843 | Antisense Oligonucleotides Targeting SCN2A Retained Introns Abandoned Abandoned Dec 2, 2024 | Abandoned | Abandoned Dec 2, 2024 | |
| 17/436,547 | Methods for the Treatment of Perimenopause and Menopause Abandoned Abandoned Mar 10, 2025 | Abandoned | Abandoned Mar 10, 2025 |